Pharmaceutical giant Genzyme withdraws MS drug in order to re-brand it and sell at 20 times the original price

Thursday, October 18, 2012 by: Ethan A. Huff, staff writer
Tags: Genzyme, MS drugs, profiteering

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
GMO crops totally banned in Russia... powerful nation blocks Monsanto's agricultural imperialism and mass poisoning of the population
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Pepsi drops aspartame from diet soda as consumers reject toxic sweetener
Bride of Frankenfood: Hillary Clinton pushes GMO agenda... hires Monsanto lobbyist... takes huge dollars from Monsanto
STATINS RED ALERT: Widely prescribed drugs act as cellular poisons that accelerate aging... deactivate DNA repair... promote diabetes, muscle fatigue and memory loss
Wild eyes and bowl cuts: Why do mass shooters always share the same hair styles and crazed zombie stares?
Mind control through emotional domination: How we're all being manipulated by the "crisis of the NOW"
(NaturalNews) Thousands of British patients suffering from the devastating chronic inflammatory disease known as multiple sclerosis (MS) now have one fewer conventional treatment option at their disposal thanks to the merciless greed of the Sanofi-owned pharmaceutical giant Genzyme. The U.K.'s Independent reports that Genzyme has intentionally withdrawn a popular MS drug known as alemtuzumab in order to re-brand it and sell it for up to 20 times its current price.

The drug, known as alemtuzumab, has been specifically licensed for the treatment of leukemia. But because it also apparently works quite well at alleviating MS symptoms in many patients, alemtuzumab is the drug of choice for many doctors successfully treating the condition. A study presented at the 64th Annual Meeting of the American Academy of Neurology back in April found that alemtuzumab actually works better than most of the other available drugs specifically approved as treatments for MS. (http://www.medicalnewstoday.com/articles/244718.php)

Just like in the U.S., off-label drug prescriptions are technically legal, which is why many doctors have chosen alemtuzumab over its various alternatives. But Genzyme, in a bid to significantly boost its profits, has decided to pull alemtuzumab from the market in order to run it through new clinical trials, and eventually re-brand it as "Lemtrada," which is expected to cost many thousands of dollars more than currently-available alemtuzumab.

"Many of us think [alemtuzumab] is the best drug for patients with aggressive MS in the early stages of the disease," says Professor John Zajicek from the University of Plymouth, one of many who is calling on the U.K. Health Secretary to stop Genzyme from restricting the drug's use. "It's the greedy behavior of the drug company that upsets me. They are just trying to re-brand it and put the price up. It is morally corrupt."

Genzyme's greed could end up needlessly killing thousands of MS patients

As a result of Genzyme's decision, alemtuzumab will now only be available as a treatment for leukemia patients, and not for MS patients. This is particularly concerning to Zajicek and many others who recognize that thousands MS patients currently rely on alemtuzumab for relief. Many people are questioning how Genzyme could be so heartless that it would pull a vital drug from the market, leaving thousands of patients without treatment.

"There is no good reason why people with MS who have been allowed to benefit from the treatment should now be denied it," Doug Brown, Head of Biomedical Research at the Multiple Sclerosis Society, is quoted as saying by the Independent. "Genzyme needs to come up with a scheme, quickly, that makes their product available to all those people currently being treated and, if it's licensed, price the drug reasonably so it is deemed cost effective on the NHS (National Health Service)."

Since MS is a chronic inflammatory disease, there are also a number of natural remedies that may help quell this serious disease and provide lasting relief without the need for pharmaceutical drugs. Here is a great article by our own Dr. David Jockers that explains some natural strategies for beating MS: http://www.naturalnews.com

Sources for this article include:


Follow real-time breaking news headlines on
Genzyme at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.